Turning Point Benefit Group’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
RCMNY
Turning Point Benefit Group's VTRS Position: Q1 2026 in Review
Turning Point Benefit Group sold out of Viatris (VTRS) in Q1 2026, closing a stake of 17 shares — an estimated $211 sold.
Turning Point Benefit Group first reported a position in VTRS in Q3 2025 and held it in 2 quarters. The position peaked at $211 in Q4 2025. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.
- Turning Point Benefit Group reported no remaining Viatris position as of Q1 2026 after selling out during the quarter.
- Turning Point Benefit Group sold 17 Viatris shares in Q1 2026, an estimated $211.
- Turning Point Benefit Group first reported a position in Viatris in Q3 2025 and held it in 2 quarters.
- Turning Point Benefit Group's Viatris position peaked at $211 in Q4 2025.
- 1,030 funds tracked by Wall St. Rank held Viatris as of Q1 2026.
Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.